{"id":47359,"date":"2022-08-16T20:02:03","date_gmt":"2022-08-16T18:02:03","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\/"},"modified":"2022-08-16T20:02:03","modified_gmt":"2022-08-16T18:02:03","slug":"vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\/","title":{"rendered":"VySpine Announces FDA Clearance for VyPlate Anterior Cervical Plate System"},"content":{"rendered":"
\n

TALLAHASSEE, Fla.–(BUSINESS WIRE)–VySpine<\/a>, a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the FDA for its VyPlate Anterior Cervical Plate System. The VyPlate ACP system is indicated for stabilization of the anterior cervical spine from C2 to C7, employing unicortical screw fixation at the anterior face of the vertebral bodies.\n<\/p>\n

\nThe VyPlate ACP System features plates and screws manufactured from titanium alloy as specified by ASTM F-136. The system\u2019s robust yet simple locking mechanism ensures that the bone screws are fully captured within the VyPlate.\n<\/p>\n

\n\u201cThe VyPlate ACP System is a unique, elegantly simple system,\u201d said Tom McLeer, CEO of VySpine. \u201cIt offers a great deal of versatility and flexibility while providing ease of use for the surgeon. The VyPlate is intuitive while also being robust and adaptable.\u201d\n<\/p>\n

\nThe VyPlate ACP System is offered in numerous sizes, ranging from single level to five level plates. The VyPlate\u2019s bone screws can either be variable (with a high degree of angulation), or in a fixed angle to the plate. Additionally, the VyPlate bone screws are available in self-drilling or self-tapping configurations. The screws come in a range of lengths and diameters to provide optimal fit with patient anatomy.\n<\/p>\n

\nAbout VySpine<\/b>\n<\/p>\n

\nVySpine was created through active internal development and the licensing of various proven technologies using innovative materials and designs. This comprehensive line of core spine products and newly developed specialty products allow us to meet the needs of both health care providers and surgeons. The company strives to outpace the competition by collaborating with key spine innovators while providing a flexible, cost-effective approach to spine care. Learn more at vyspine.com<\/a>\n<\/p>\n

\n\u201cVySpine\u201d and \u201cVyPlate\u201d are registered trademarks of VySpine.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nPaul Williams, 310-569-0023, paul@medialinecommunications.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TALLAHASSEE, Fla.–(BUSINESS WIRE)–VySpine, a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the FDA for its VyPlate Anterior Cervical Plate System. The VyPlate ACP system is indicated for stabilization of the anterior cervical spine from C2 to C7, employing unicortical screw fixation at the anterior face … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47359","6":"format-standard","7":"category-industry"},"yoast_head":"\nVySpine Announces FDA Clearance for VyPlate Anterior Cervical Plate System - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VySpine Announces FDA Clearance for VyPlate Anterior Cervical Plate System - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TALLAHASSEE, Fla.–(BUSINESS WIRE)–VySpine, a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the FDA for its VyPlate Anterior Cervical Plate System. The VyPlate ACP system is indicated for stabilization of the anterior cervical spine from C2 to C7, employing unicortical screw fixation at the anterior face ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-16T18:02:03+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"VySpine Announces FDA Clearance for VyPlate Anterior Cervical Plate System\",\"datePublished\":\"2022-08-16T18:02:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\\\/\"},\"wordCount\":309,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\\\/\",\"name\":\"VySpine Announces FDA Clearance for VyPlate Anterior Cervical Plate System - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-08-16T18:02:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VySpine Announces FDA Clearance for VyPlate Anterior Cervical Plate System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VySpine Announces FDA Clearance for VyPlate Anterior Cervical Plate System - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\/","og_locale":"en_US","og_type":"article","og_title":"VySpine Announces FDA Clearance for VyPlate Anterior Cervical Plate System - Pharma Trend","og_description":"TALLAHASSEE, Fla.–(BUSINESS WIRE)–VySpine, a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the FDA for its VyPlate Anterior Cervical Plate System. The VyPlate ACP system is indicated for stabilization of the anterior cervical spine from C2 to C7, employing unicortical screw fixation at the anterior face ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-16T18:02:03+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"VySpine Announces FDA Clearance for VyPlate Anterior Cervical Plate System","datePublished":"2022-08-16T18:02:03+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\/"},"wordCount":309,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\/","url":"https:\/\/pharma-trend.com\/en\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\/","name":"VySpine Announces FDA Clearance for VyPlate Anterior Cervical Plate System - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-08-16T18:02:03+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/vyspine-announces-fda-clearance-for-vyplate-anterior-cervical-plate-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"VySpine Announces FDA Clearance for VyPlate Anterior Cervical Plate System"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47359"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47359\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}